Categories
Delhi News

CIPLA | Earnings prospects improve on both domestic and US business front | Stock Of The Day



Cipla is amongst the leading pharmaceuticals having a significant presence in two key markets – Indian and the US. It is chiefly known for respiratory therapies due which its products were is in demand during COVID pandemic. It commands a sizeable share in chronic therapies, with a presence in cardiovascular, diabetic and respiratory therapies.
#stocks #cipla #stockmarket

Moneycontrol is India’s leading financial and business portal with in-depth market coverage, analysis, expert opinions, and a gamut of financial tools.
A part of Network18, moneycontrol.com is the most influential destination for stock market news and advice, business news, and news about the Indian and global economy.
Subscribe:
Follow us:
Visit
Facebook:
Twitter:
Instagram:

source

Contact Us for Insurance Needs in Rohini, Delhi, Pitampura

We are a group of best insurance advisors in Delhi. We are experts in LIC and have received number of awards.
If you are near Delhi or Rohini or Pitampura Contact Us Here